NEUROPACE, INC. (NPCE) Current Ratio
- Current ratio · latest quarter: Value 4.94×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.94× | Current assets / current liabilities. $86.19M ÷ $17.43M ≈ 4.94× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 86.19M USD | Assets, Current |
| Current obligations | 17.43M USD | Liabilities, Current |
| Cash and equivalents | 12.54M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 14.93M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 18.11M USD | Inventory, Net |
| Payables | 4.20M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $86.19M | $17.43M | $12.54M | (m) | $14.93M | $18.11M | $4.20M | (m) | 4.94× |
| 2026-03-31 | $86.98M | $16.17M | $14.78M | (m) | $14.79M | $16.69M | $4.51M | (m) | 5.38× |
| 2025-12-31 | $94.07M | $17.81M | $21.69M | (m) | $12.94M | $14.86M | $1.78M | (m) | 5.28× |
| 2025-09-30 | $95.33M | $19.61M | $20.65M | (m) | $14.94M | $18.14M | $4.59M | (m) | 4.86× |
| 2025-06-30 | $93.74M | $17.14M | $22.86M | (m) | $13.55M | $16.35M | $4.72M | (m) | 5.47× |
| 2025-03-31 | $97.48M | $14.71M | $27.02M | (m) | $15.44M | $13.58M | $4.05M | (m) | 6.63× |
| 2024-12-31 | $81.34M | $15.16M | $13.43M | (m) | $12.85M | $13.38M | $2.95M | (m) | 5.37× |
| 2024-09-30 | $82.59M | $14.78M | $15.42M | (m) | $11.56M | $12.08M | $2.16M | (m) | 5.59× |
| 2024-06-30 | $80.23M | $12.59M | $12.84M | (m) | $11.24M | $11.36M | $2.29M | (m) | 6.37× |
| 2024-03-31 | $84.25M | $13.11M | $13.00M | (m) | $11.63M | $11.42M | $3.27M | (m) | 6.43× |
| 2023-12-31 | $92.72M | $16.23M | $18.06M | (m) | $12.31M | $11.21M | $2.33M | (m) | 5.71× |
| 2023-09-30 | $83.97M | $12.81M | $9.72M | (m) | $11.28M | $9.76M | $1.21M | (m) | 6.55× |
| 2023-06-30 | $86.51M | $11.51M | $7.86M | (m) | $10.88M | $10.01M | $1.81M | (m) | 7.52× |
| 2023-03-31 | $90.16M | $9.88M | $6.72M | (m) | $9.19M | $10.75M | $1.83M | (m) | 9.13× |
| 2022-12-31 | $97.71M | $10.98M | $6.61M | (m) | $7.48M | $9.71M | $2.15M | (m) | 8.90× |
| 2022-09-30 | $104.37M | $9.42M | $5.69M | $79.72M | $7.88M | $8.58M | $1.18M | (m) | 11.08× |
| 2022-06-30 | $112.46M | $11.40M | $5.70M | $86.71M | $8.47M | $8.42M | $1.50M | (m) | 9.86× |
| 2022-03-31 | $122.42M | $12.06M | $7.49M | $95.69M | $9.06M | $8.10M | $2.23M | (m) | 10.15× |
| 2021-12-31 | $132.82M | $9.30M | $19.19M | (m) | $7.09M | $7.82M | $1.38M | (m) | 14.28× |
| 2021-09-30 | $140.49M | $8.67M | $26.63M | $96.70M | $6.61M | $7.16M | $1.25M | $0.00 | 16.20× |
| 2021-06-30 | $146.40M | $7.61M | $31.25M | $96.67M | $7.71M | $6.96M | $968.00K | $0.00 | 19.24× |
| 2021-03-31 | $47.09M | $10.81M | $13.84M | $16.69M | $8.20M | $7.04M | $1.48M | $3.59M | 4.36× |
| 2020-12-31 | $54.56M | $9.60M | $26.39M | (m) | $8.39M | $6.91M | $949.00K | $2.04M | 5.69× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |